| Acute tumefactive demyelinating lesions in a pediatric patient with known diagnosis of multiple sclerosis: review of the literature and treatment proposal. | |
| | |
MedLine Citation:
|
PMID: 19189932 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Tumefactive demyelinating lesions are a known but uncommon complication of multiple sclerosis, a disease rarely reported in children. This is the case of a 16-year-old African American patient with multiple sclerosis, who developed 2 tumefactive demyelinating lesions. Review of the literature and our own experience helped formulate an algorithm for therapeutic options during an acute attack. |
| | |
Authors:
|
Jahannaz Dastgir; Francis J DiMario |
Publication Detail:
|
Type: Case Reports; Journal Article Date: 2009-02-02 |
Journal Detail:
|
Title: Journal of child neurology Volume: 24 ISSN: 1708-8283 ISO Abbreviation: J. Child Neurol. Publication Date: 2009 Apr |
Date Detail:
|
Created Date: 2009-04-02 Completed Date: 2009-08-14 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8606714 Medline TA: J Child Neurol Country: United States |
Other Details:
|
Languages: eng Pagination: 431-7 Citation Subset: IM |
Affiliation:
|
Department of Pediatrics, Division of Child Neurology, Connecticut Children's Medical Center, Hartford, Connecticut 06106, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acute Disease
/
therapy Adolescent Brain / pathology*, physiopathology Cyclophosphamide / therapeutic use Demyelinating Diseases / pathology*, physiopathology, therapy Facial Nerve Diseases / etiology Frontal Lobe / pathology, physiopathology Hemiplegia / etiology Humans Immunoglobulins, Intravenous / therapeutic use Immunosuppressive Agents / therapeutic use Interferon-beta / therapeutic use Magnetic Resonance Imaging Male Methylprednisolone / therapeutic use Multiple Sclerosis / pathology*, physiopathology, therapy Nerve Fibers, Myelinated / pathology Ocular Motility Disorders / etiology Paresis / etiology Pons / pathology, physiopathology Recurrence Treatment Outcome Vertigo / etiology |
| Chemical | |
Reg. No./Substance:
|
0/Immunoglobulins, Intravenous; 0/Immunosuppressive Agents; 145258-61-3/interferon beta 1a; 50-18-0/Cyclophosphamide; 77238-31-4/Interferon-beta; 83-43-2/Methylprednisolone |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Methyl-CpG-binding Protein 2 (MECP2) Gene Mutations in an Italian Sample of Patients with Pervasive ...
Next Document: Kindergarten Children's Failure to Qualify for First Grade Could Result From Sleep Disturbances.